Literature DB >> 157060

Comparative effects of drugs on four paw oedema models in the rat.

D K Gemmell, J Cottney, A J Lewis.   

Abstract

The development of novel anti-inflammatory drugs (AID) has been claimed to be dependent on the discovery of models of inflammation that differ from those currently used for drug screening, e.g. carrageenen paw oedema and u.v. erythema. We have thus evaluated the effect of a variety of drugs in a number of novel models of inflammation in the rat produced in the hind paw. We have utilized kaolin, zymosan, anti-rat IgG (anti-IgG) and the Reversed Passive Arthus (RPA) reaction to produce these oedema models. We found that the non-steroidal AID's, e.g. aspirin, flufenamic acid, indomethacin, naproxen, and phenylbutazone, were active in all four tests. Of the nine novel AID examined, levamisole and tetramisole demonstrated considerable activity in all four tests and dapsone was especially active in the anti-IgG and RPA tests. In contrast, the anti-rheumatic d-penicillamine was inactive in all four models. Each of the ten compounds tested which has been claimed to influence complement function, was active in the RPA but not in the kaolin model. These results are discussed in the context of the aetiology of each oedema and the suspected mode of action of the various drugs.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 157060     DOI: 10.1007/bf02024141

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  32 in total

Review 1.  Miscellaneous antirheumatic drugs and their possible modes of action.

Authors:  P Bresloff
Journal:  Adv Drug Res       Date:  1977

2.  Site of deposition of C3 in Arthus reactions of C4 deficient guinea pigs.

Authors:  M M Frank; E I Green; C G Cochrane
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

3.  Chlorphenesin: a new inhibitor IgE-mediated histamine release.

Authors:  L M Lichtenstein; N F Adkinson
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

4.  Anticomplementary properties of cinnarizine.

Authors:  T Di Perri
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-05

5.  Anti-inflammatory mechanism of inflamed-tissue factor.

Authors:  I L Bonta; J Noordhoek
Journal:  Agents Actions       Date:  1973-12

6.  Prostaglandins and leucocyte migration in inflammatory reactions.

Authors:  A W Ford-Hutchinson; J R Walker; N S Connor; M J Smith
Journal:  Agents Actions       Date:  1977-10

7.  Mechanism of action of colchicine. I. Effect of colchicine and its analogs on the reversed passive Arthus reaction and the carrageenan-induced hindpaw edema in the rat.

Authors:  Y H Chang
Journal:  J Pharmacol Exp Ther       Date:  1975-07       Impact factor: 4.030

8.  Dapsone in rheumatoid arthritis.

Authors:  B McConkey; P Davies; R A Crockson; A P Crockson; M Butler; T J Constable
Journal:  Rheumatol Rehabil       Date:  1976-08

9.  Mechanisms of phytohaemagglutinin-P-, concanavalin-A- and kaolin-induced oedemas in the rat.

Authors:  A J Lewis; J Cottney; D J Nelson
Journal:  Eur J Pharmacol       Date:  1976-11       Impact factor: 4.432

10.  Mechanisms of immunologic injury of rat peritoneal mast cells. II. Complement requirement and phosphonate ester inhibition of release of histamine by rabbit anti-rat gamma globulin.

Authors:  K F Austen; E L Becker
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

View more
  14 in total

1.  Assessment of antiinflammatory agents using 125I-labeled human serum albumin to quantify footpad edema volume in the rat.

Authors:  D J Ormrod; T E Miller
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

Review 2.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

3.  Kinins and peritoneal exudates induced by carrageenin and zymosan in rats.

Authors:  J Damas; V Bourdon; G Remacle-Volon; A Adam
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense.

Authors:  U Siemoneit; A Koeberle; A Rossi; F Dehm; M Verhoff; S Reckel; T J Maier; J Jauch; H Northoff; F Bernhard; V Doetsch; L Sautebin; O Werz
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

5.  The anti-inflammatory profile of dapsone in animal models of inflammation.

Authors:  A J Lewis; D K Gemmell; W H Stimson
Journal:  Agents Actions       Date:  1978-12

6.  Anti-inflammatory effect of LA 2851 and reference drugs on some models of inflammation. Investigation of the mechanism of action.

Authors:  J L Junien; C Lakatos; J Brohon; M Guillaume; J Sterne
Journal:  Agents Actions       Date:  1982-10

7.  Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats.

Authors:  K Phadke; J Carroll; S Nanda
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Anti-inflammatory and analgesic effects of magnolol.

Authors:  J P Wang; M F Hsu; S L Raung; C C Chen; J S Kuo; C M Teng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

9.  Further studies of the mechanism of counter irritation by turpentine.

Authors:  J Damas; G Remacle-Volon; E Deflandre
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

10.  Action of gold salts in some inflammatory and immunological models.

Authors:  A J Lewis; J Cottney; D D White; P K Fox; A McNeillie; J Dunlop; W E Smith; D H Brown
Journal:  Agents Actions       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.